Nitrogen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with the administration of Nitrogen, which may be contraindicated in certain circumstances. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Administration of Nitrogen is associated with potential hazards and contraindications. It is intended for use solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

The route of administration for Nitrogen is via respiratory inhalation. It is imperative that healthcare professionals adhere to established protocols and guidelines when administering this substance to ensure patient safety and therapeutic efficacy.

Contraindications

There are no specific contraindications identified for this product. However, the following precautions should be observed to ensure safe handling and use:

• Handling should only occur after all safety precautions have been thoroughly read and understood.

• The product must be used and stored exclusively outdoors or in a well-ventilated area to mitigate risks associated with potential exposure.

• Use is restricted to equipment that is rated for cylinder pressure to prevent equipment failure or accidents.

• Protection from sunlight is necessary when ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit) to avoid degradation or hazardous conditions.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazardous Properties

Nitrogen is classified as a refrigerated gas, which may lead to cryogenic burns or injuries upon contact. Additionally, it is important to note that Nitrogen can displace oxygen in the environment, potentially resulting in rapid suffocation. Furthermore, as a gas under pressure, it poses an explosion risk if subjected to heat.

General Precautions

Prior to handling Nitrogen, it is essential that all safety precautions are thoroughly read and understood. The use and storage of Nitrogen should be conducted exclusively outdoors or in a well-ventilated area. Personal protective equipment, including cold insulating gloves, a face shield, and eye protection, must be worn at all times. A backflow preventive device should be utilized in the piping to mitigate risks. Connections should never be changed or forced, and the valve must be closed after each use and when the container is empty. It is also critical to protect Nitrogen from sunlight when ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit). Users are advised to read and adhere to the Safety Data Sheet (SDS) prior to use.

Emergency Medical Assistance

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice and attention should be sought immediately.

If Nitrogen comes into contact with the skin, it is important to thaw any frostbitten areas with lukewarm water without rubbing the affected region. Immediate medical advice and attention should also be obtained in this scenario.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious warnings include the presence of gas under pressure, which may lead to an explosion if heated. Additionally, the product may displace oxygen, posing a risk of rapid suffocation.

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice and attention should be sought promptly to address any complications that may arise.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. The potential risks and benefits should be carefully weighed in the context of the individual patient's situation.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs. Instances of cryogenic burns or injury have been associated with exposure to refrigerated gas. Additionally, cases of rapid suffocation due to oxygen displacement have been documented.

Patient Counseling

Healthcare providers should advise patients to always keep the container in an upright position to ensure safe handling. It is crucial to inform patients not to change or force fit connections, as this may lead to hazardous situations.

Patients should be made aware that the administration of Nitrogen may be hazardous or contraindicated. It is intended for use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Nitrogen. This practitioner should be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Healthcare providers must emphasize the warning that the product contains refrigerated gas, which may cause cryogenic burns or injury. Additionally, it may displace oxygen and lead to rapid suffocation. Patients should be instructed to handle the product only after reading and understanding all safety precautions.

It is important to counsel patients to use and store the product only outdoors or in a well-ventilated area. They should be advised to wear cold insulating gloves, a face shield, and eye protection during handling. The use of a backflow preventive device in the piping is also recommended to ensure safety.

Patients should be reminded to close the valve after each use and when the container is empty. They should read and follow the Safety Data Sheet (SDS) before use to understand the risks involved.

In the event of an emergency, healthcare providers should instruct patients on first aid measures. If Nitrogen is inhaled, patients should be removed to fresh air and kept comfortable for breathing. If the gas comes into contact with skin, patients should thaw frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Finally, it is essential to inform patients that the product contains gas under pressure, which may explode if heated. They should be cautioned that it may also displace oxygen and cause rapid suffocation. Patients should only use equipment rated for cylinder pressure and protect the container from sunlight when the ambient temperature exceeds 52 degrees C (125 degrees F).

Storage and Handling

The product is supplied in containers that must always be kept in an upright position. It is essential to avoid changing or force-fitting connections during use. The product should be utilized and stored exclusively outdoors or in a well-ventilated area to ensure safety and efficacy.

After each use and when the container is empty, the valve must be closed to prevent any potential leaks or hazards. Additionally, it is crucial to protect the product from sunlight, particularly when the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit).

For safe handling, a backflow preventive device should be employed in the piping system. Users are strongly advised to read and follow the Safety Data Sheet (SDS) prior to use to ensure proper handling and safety measures are observed.

Additional Clinical Information

Patients should be aware that the route of administration for this product is via respiratory inhalation. It is crucial that administration is conducted only by or under the supervision of a licensed practitioner experienced in the use of Nitrogen, who understands the indications, effects, dosages, methods, and potential hazards associated with its use.

Clinicians must inform patients of the significant risks involved, including the potential for cryogenic burns or injury due to the refrigerated gas, as well as the risk of oxygen displacement leading to rapid suffocation. Safety precautions are essential; patients should ensure they read and understand all safety guidelines before handling the product. It is recommended to use and store the gas outdoors or in well-ventilated areas, and to wear appropriate protective gear, including cold insulating gloves, face shields, and eye protection. Additionally, a backflow preventive device should be utilized in the piping, and valves should be closed after each use and when empty.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by AGP LLC. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)